Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent

NCT03516942 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT03516942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03516942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Observational
Overall status
Active, not recruiting
Start date
June 11, 2018
Completion date
September 1, 2028
Enrollment
565 (actual)
Sites
716

Conditions

As the registry lists them; a condition with its own page is linked.

stage i colon cancer ajcc v8, stage i rectal cancer ajcc v8, stage ii colon cancer ajcc v8, stage ii rectal cancer ajcc v8, stage iia colon cancer ajcc v8, stage iia rectal cancer ajcc v8, stage iib colon cancer ajcc v8, stage iib rectal cancer ajcc v8, stage iic colon cancer ajcc v8, stage iic rectal cancer ajcc v8, stage iii colon cancer ajcc v8, stage iii rectal cancer ajcc v8, stage iiia colon cancer ajcc v8, stage iiia rectal cancer ajcc v8, stage iiib colon cancer ajcc v8, stage iiib rectal cancer ajcc v8, stage iiic colon cancer ajcc v8, stage iiic rectal cancer ajcc v8